Stonepine Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-985,210
| Closed | -$10.3M | – | 28 |
|
|
2017
Q3 | $10.3M | Buy |
985,210
+237,347
| +32% | +$2.49M | 6.1% | 8 |
|
|
2017
Q2 | $8.25M | Sell |
747,863
-4,547
| -0.6% | -$50.2K | 4.45% | 9 |
|
|
2017
Q1 | $7.28M | Buy |
752,410
+426,323
| +131% | +$4.13M | 4.1% | 10 |
|
|
2016
Q4 | $3.39M | Buy |
+326,087
| New | +$3.39M | 2.02% | 16 |
|
|
2016
Q3 | – | Sell |
-128,005
| Closed | -$1.38M | – | 18 |
|
|
2016
Q2 | $1.38M | Buy |
+128,005
| New | +$1.38M | 1.41% | 16 |
|